Cystic fibrosis pulmonary guidelines: Pulmonary complications: Hemoptysis and pneumothorax

Patrick A. Flume, Peter J. Mogayzel, Karen A. Robinson, Randall L. Rosenblatt, Lynne Quittell, Bruce C. Marshall, James Cunningham, Anne Downs, Jill Fleige, Chris Goss, Hector Gutierrez, Leslie Hazle, Robert Kuhn, Mary Lester, Kathryn Sabadosa, Robert L. Vender, Terry B. White, Donna Beth Willey-Courand, Melissa Chin, Carlos E. MillaJeff Wagener, Christopher M. Oermann, Thomas Ferkol, Wyn Hoover, Michelle S. Howenstine, Michael J. Rock, George Retsch-Bogart, Ronald Rubenstein, Michael Schechter, David M. Orenstein, John Louis Colombo, Beryl Rosenstein, Henry L. Dorkin, James D. Acton, Susanna A. McColley, Felix Ratjen, Moira L. Aitken, Paul Mohabir, Jerry A. Nick, Marcia Katz, Daniel Rosenbluth, Randall K. Young, Aruna Sannuti, Guillermo A. DoPico, James R. Yankaskas, Douglas Holsclaw, Linda L. Wolfenden, Joseph M. Pilewski, Peter J Murphy, Michael P. Boyle, Ahmet Uluer, Steven D. Strausbaugh, Patricia M. Joseph, Manu Jain, Elizabeth Tullis, Souheil Saddekni, Patricia Burrows, Mark Wholey, Charles Burke, Mark Sands, Sally Mitchell, R. Duane Davis, Thomas M. Egan, Charles B. Huddleston, Mike Mulligan, David McGiffin, Wickii Vigneswaran, Craig Lillehei

Research output: Contribution to journalReview article

121 Citations (Scopus)

Abstract

Rationale: Cystic fibrosis (CF) is a recessive genetic disease characterized by dehydration of the airway surface liquid and impaired mucociliary clearance. As a result, individuals with the disease have difficulty clearing pathogens from the lung and experience chronic pulmonary infections and inflammation. There may be intermittent pulmonary exacerbations or acute worsening of infection and obstruction, which require more intensive therapies. Hemoptysis and pneumothorax are complications commonly reported in patients with cystic fibrosis. Objectives: This document presents the CF Foundation's Pulmonary Therapies Committee recommendations for the treatment of hemoptysis and pneumothorax. Methods: The committee recognized that insufficient data exist to develop evidence-based recommendations and so used the Delphi technique to formalize an expert panel's consensus process and develop explicit care recommendations. Measurements and Main Results: The expert panel completed the survey twice, allowing refinement of recommendations. Numeric responses to the questions were summarized and applied to a priori definitions to determine levels of consensus. Recommendations were then developed to practical treatment questions based upon the median scores and the degree of consensus. Conclusions: These recommendations for the management of the patient with CF with hemoptysis and pneumothorax are designed for general use in most individuals but should be adapted to meet specific needs as determined by the individuals, their families, and their health care providers. It ishopedthat the guidelines providedin this manuscript will facilitate the appropriate application of these treatments to improve and extend the lives of all individuals with cystic fibrosis.

Original languageEnglish (US)
Pages (from-to)298-306
Number of pages9
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume182
Issue number3
DOIs
StatePublished - Aug 1 2010

Fingerprint

Hemoptysis
Pneumothorax
Cystic Fibrosis
Guidelines
Lung
Delphi Technique
Mucociliary Clearance
Therapeutics
Inborn Genetic Diseases
Family Health
Infection
Dehydration
Health Personnel
Pneumonia

Keywords

  • Complications
  • Cystic fibrosis
  • Guidelines
  • Hemoptysis
  • Pneumothorax

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Flume, P. A., Mogayzel, P. J., Robinson, K. A., Rosenblatt, R. L., Quittell, L., Marshall, B. C., ... Lillehei, C. (2010). Cystic fibrosis pulmonary guidelines: Pulmonary complications: Hemoptysis and pneumothorax. American Journal of Respiratory and Critical Care Medicine, 182(3), 298-306. https://doi.org/10.1164/rccm.201002-0157OC

Cystic fibrosis pulmonary guidelines : Pulmonary complications: Hemoptysis and pneumothorax. / Flume, Patrick A.; Mogayzel, Peter J.; Robinson, Karen A.; Rosenblatt, Randall L.; Quittell, Lynne; Marshall, Bruce C.; Cunningham, James; Downs, Anne; Fleige, Jill; Goss, Chris; Gutierrez, Hector; Hazle, Leslie; Kuhn, Robert; Lester, Mary; Sabadosa, Kathryn; Vender, Robert L.; White, Terry B.; Willey-Courand, Donna Beth; Chin, Melissa; Milla, Carlos E.; Wagener, Jeff; Oermann, Christopher M.; Ferkol, Thomas; Hoover, Wyn; Howenstine, Michelle S.; Rock, Michael J.; Retsch-Bogart, George; Rubenstein, Ronald; Schechter, Michael; Orenstein, David M.; Colombo, John Louis; Rosenstein, Beryl; Dorkin, Henry L.; Acton, James D.; McColley, Susanna A.; Ratjen, Felix; Aitken, Moira L.; Mohabir, Paul; Nick, Jerry A.; Katz, Marcia; Rosenbluth, Daniel; Young, Randall K.; Sannuti, Aruna; DoPico, Guillermo A.; Yankaskas, James R.; Holsclaw, Douglas; Wolfenden, Linda L.; Pilewski, Joseph M.; Murphy, Peter J; Boyle, Michael P.; Uluer, Ahmet; Strausbaugh, Steven D.; Joseph, Patricia M.; Jain, Manu; Tullis, Elizabeth; Saddekni, Souheil; Burrows, Patricia; Wholey, Mark; Burke, Charles; Sands, Mark; Mitchell, Sally; Davis, R. Duane; Egan, Thomas M.; Huddleston, Charles B.; Mulligan, Mike; McGiffin, David; Vigneswaran, Wickii; Lillehei, Craig.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 182, No. 3, 01.08.2010, p. 298-306.

Research output: Contribution to journalReview article

Flume, PA, Mogayzel, PJ, Robinson, KA, Rosenblatt, RL, Quittell, L, Marshall, BC, Cunningham, J, Downs, A, Fleige, J, Goss, C, Gutierrez, H, Hazle, L, Kuhn, R, Lester, M, Sabadosa, K, Vender, RL, White, TB, Willey-Courand, DB, Chin, M, Milla, CE, Wagener, J, Oermann, CM, Ferkol, T, Hoover, W, Howenstine, MS, Rock, MJ, Retsch-Bogart, G, Rubenstein, R, Schechter, M, Orenstein, DM, Colombo, JL, Rosenstein, B, Dorkin, HL, Acton, JD, McColley, SA, Ratjen, F, Aitken, ML, Mohabir, P, Nick, JA, Katz, M, Rosenbluth, D, Young, RK, Sannuti, A, DoPico, GA, Yankaskas, JR, Holsclaw, D, Wolfenden, LL, Pilewski, JM, Murphy, PJ, Boyle, MP, Uluer, A, Strausbaugh, SD, Joseph, PM, Jain, M, Tullis, E, Saddekni, S, Burrows, P, Wholey, M, Burke, C, Sands, M, Mitchell, S, Davis, RD, Egan, TM, Huddleston, CB, Mulligan, M, McGiffin, D, Vigneswaran, W & Lillehei, C 2010, 'Cystic fibrosis pulmonary guidelines: Pulmonary complications: Hemoptysis and pneumothorax', American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 3, pp. 298-306. https://doi.org/10.1164/rccm.201002-0157OC
Flume, Patrick A. ; Mogayzel, Peter J. ; Robinson, Karen A. ; Rosenblatt, Randall L. ; Quittell, Lynne ; Marshall, Bruce C. ; Cunningham, James ; Downs, Anne ; Fleige, Jill ; Goss, Chris ; Gutierrez, Hector ; Hazle, Leslie ; Kuhn, Robert ; Lester, Mary ; Sabadosa, Kathryn ; Vender, Robert L. ; White, Terry B. ; Willey-Courand, Donna Beth ; Chin, Melissa ; Milla, Carlos E. ; Wagener, Jeff ; Oermann, Christopher M. ; Ferkol, Thomas ; Hoover, Wyn ; Howenstine, Michelle S. ; Rock, Michael J. ; Retsch-Bogart, George ; Rubenstein, Ronald ; Schechter, Michael ; Orenstein, David M. ; Colombo, John Louis ; Rosenstein, Beryl ; Dorkin, Henry L. ; Acton, James D. ; McColley, Susanna A. ; Ratjen, Felix ; Aitken, Moira L. ; Mohabir, Paul ; Nick, Jerry A. ; Katz, Marcia ; Rosenbluth, Daniel ; Young, Randall K. ; Sannuti, Aruna ; DoPico, Guillermo A. ; Yankaskas, James R. ; Holsclaw, Douglas ; Wolfenden, Linda L. ; Pilewski, Joseph M. ; Murphy, Peter J ; Boyle, Michael P. ; Uluer, Ahmet ; Strausbaugh, Steven D. ; Joseph, Patricia M. ; Jain, Manu ; Tullis, Elizabeth ; Saddekni, Souheil ; Burrows, Patricia ; Wholey, Mark ; Burke, Charles ; Sands, Mark ; Mitchell, Sally ; Davis, R. Duane ; Egan, Thomas M. ; Huddleston, Charles B. ; Mulligan, Mike ; McGiffin, David ; Vigneswaran, Wickii ; Lillehei, Craig. / Cystic fibrosis pulmonary guidelines : Pulmonary complications: Hemoptysis and pneumothorax. In: American Journal of Respiratory and Critical Care Medicine. 2010 ; Vol. 182, No. 3. pp. 298-306.
@article{e16f4fd933774b5085820e408984639b,
title = "Cystic fibrosis pulmonary guidelines: Pulmonary complications: Hemoptysis and pneumothorax",
abstract = "Rationale: Cystic fibrosis (CF) is a recessive genetic disease characterized by dehydration of the airway surface liquid and impaired mucociliary clearance. As a result, individuals with the disease have difficulty clearing pathogens from the lung and experience chronic pulmonary infections and inflammation. There may be intermittent pulmonary exacerbations or acute worsening of infection and obstruction, which require more intensive therapies. Hemoptysis and pneumothorax are complications commonly reported in patients with cystic fibrosis. Objectives: This document presents the CF Foundation's Pulmonary Therapies Committee recommendations for the treatment of hemoptysis and pneumothorax. Methods: The committee recognized that insufficient data exist to develop evidence-based recommendations and so used the Delphi technique to formalize an expert panel's consensus process and develop explicit care recommendations. Measurements and Main Results: The expert panel completed the survey twice, allowing refinement of recommendations. Numeric responses to the questions were summarized and applied to a priori definitions to determine levels of consensus. Recommendations were then developed to practical treatment questions based upon the median scores and the degree of consensus. Conclusions: These recommendations for the management of the patient with CF with hemoptysis and pneumothorax are designed for general use in most individuals but should be adapted to meet specific needs as determined by the individuals, their families, and their health care providers. It ishopedthat the guidelines providedin this manuscript will facilitate the appropriate application of these treatments to improve and extend the lives of all individuals with cystic fibrosis.",
keywords = "Complications, Cystic fibrosis, Guidelines, Hemoptysis, Pneumothorax",
author = "Flume, {Patrick A.} and Mogayzel, {Peter J.} and Robinson, {Karen A.} and Rosenblatt, {Randall L.} and Lynne Quittell and Marshall, {Bruce C.} and James Cunningham and Anne Downs and Jill Fleige and Chris Goss and Hector Gutierrez and Leslie Hazle and Robert Kuhn and Mary Lester and Kathryn Sabadosa and Vender, {Robert L.} and White, {Terry B.} and Willey-Courand, {Donna Beth} and Melissa Chin and Milla, {Carlos E.} and Jeff Wagener and Oermann, {Christopher M.} and Thomas Ferkol and Wyn Hoover and Howenstine, {Michelle S.} and Rock, {Michael J.} and George Retsch-Bogart and Ronald Rubenstein and Michael Schechter and Orenstein, {David M.} and Colombo, {John Louis} and Beryl Rosenstein and Dorkin, {Henry L.} and Acton, {James D.} and McColley, {Susanna A.} and Felix Ratjen and Aitken, {Moira L.} and Paul Mohabir and Nick, {Jerry A.} and Marcia Katz and Daniel Rosenbluth and Young, {Randall K.} and Aruna Sannuti and DoPico, {Guillermo A.} and Yankaskas, {James R.} and Douglas Holsclaw and Wolfenden, {Linda L.} and Pilewski, {Joseph M.} and Murphy, {Peter J} and Boyle, {Michael P.} and Ahmet Uluer and Strausbaugh, {Steven D.} and Joseph, {Patricia M.} and Manu Jain and Elizabeth Tullis and Souheil Saddekni and Patricia Burrows and Mark Wholey and Charles Burke and Mark Sands and Sally Mitchell and Davis, {R. Duane} and Egan, {Thomas M.} and Huddleston, {Charles B.} and Mike Mulligan and David McGiffin and Wickii Vigneswaran and Craig Lillehei",
year = "2010",
month = "8",
day = "1",
doi = "10.1164/rccm.201002-0157OC",
language = "English (US)",
volume = "182",
pages = "298--306",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "3",

}

TY - JOUR

T1 - Cystic fibrosis pulmonary guidelines

T2 - Pulmonary complications: Hemoptysis and pneumothorax

AU - Flume, Patrick A.

AU - Mogayzel, Peter J.

AU - Robinson, Karen A.

AU - Rosenblatt, Randall L.

AU - Quittell, Lynne

AU - Marshall, Bruce C.

AU - Cunningham, James

AU - Downs, Anne

AU - Fleige, Jill

AU - Goss, Chris

AU - Gutierrez, Hector

AU - Hazle, Leslie

AU - Kuhn, Robert

AU - Lester, Mary

AU - Sabadosa, Kathryn

AU - Vender, Robert L.

AU - White, Terry B.

AU - Willey-Courand, Donna Beth

AU - Chin, Melissa

AU - Milla, Carlos E.

AU - Wagener, Jeff

AU - Oermann, Christopher M.

AU - Ferkol, Thomas

AU - Hoover, Wyn

AU - Howenstine, Michelle S.

AU - Rock, Michael J.

AU - Retsch-Bogart, George

AU - Rubenstein, Ronald

AU - Schechter, Michael

AU - Orenstein, David M.

AU - Colombo, John Louis

AU - Rosenstein, Beryl

AU - Dorkin, Henry L.

AU - Acton, James D.

AU - McColley, Susanna A.

AU - Ratjen, Felix

AU - Aitken, Moira L.

AU - Mohabir, Paul

AU - Nick, Jerry A.

AU - Katz, Marcia

AU - Rosenbluth, Daniel

AU - Young, Randall K.

AU - Sannuti, Aruna

AU - DoPico, Guillermo A.

AU - Yankaskas, James R.

AU - Holsclaw, Douglas

AU - Wolfenden, Linda L.

AU - Pilewski, Joseph M.

AU - Murphy, Peter J

AU - Boyle, Michael P.

AU - Uluer, Ahmet

AU - Strausbaugh, Steven D.

AU - Joseph, Patricia M.

AU - Jain, Manu

AU - Tullis, Elizabeth

AU - Saddekni, Souheil

AU - Burrows, Patricia

AU - Wholey, Mark

AU - Burke, Charles

AU - Sands, Mark

AU - Mitchell, Sally

AU - Davis, R. Duane

AU - Egan, Thomas M.

AU - Huddleston, Charles B.

AU - Mulligan, Mike

AU - McGiffin, David

AU - Vigneswaran, Wickii

AU - Lillehei, Craig

PY - 2010/8/1

Y1 - 2010/8/1

N2 - Rationale: Cystic fibrosis (CF) is a recessive genetic disease characterized by dehydration of the airway surface liquid and impaired mucociliary clearance. As a result, individuals with the disease have difficulty clearing pathogens from the lung and experience chronic pulmonary infections and inflammation. There may be intermittent pulmonary exacerbations or acute worsening of infection and obstruction, which require more intensive therapies. Hemoptysis and pneumothorax are complications commonly reported in patients with cystic fibrosis. Objectives: This document presents the CF Foundation's Pulmonary Therapies Committee recommendations for the treatment of hemoptysis and pneumothorax. Methods: The committee recognized that insufficient data exist to develop evidence-based recommendations and so used the Delphi technique to formalize an expert panel's consensus process and develop explicit care recommendations. Measurements and Main Results: The expert panel completed the survey twice, allowing refinement of recommendations. Numeric responses to the questions were summarized and applied to a priori definitions to determine levels of consensus. Recommendations were then developed to practical treatment questions based upon the median scores and the degree of consensus. Conclusions: These recommendations for the management of the patient with CF with hemoptysis and pneumothorax are designed for general use in most individuals but should be adapted to meet specific needs as determined by the individuals, their families, and their health care providers. It ishopedthat the guidelines providedin this manuscript will facilitate the appropriate application of these treatments to improve and extend the lives of all individuals with cystic fibrosis.

AB - Rationale: Cystic fibrosis (CF) is a recessive genetic disease characterized by dehydration of the airway surface liquid and impaired mucociliary clearance. As a result, individuals with the disease have difficulty clearing pathogens from the lung and experience chronic pulmonary infections and inflammation. There may be intermittent pulmonary exacerbations or acute worsening of infection and obstruction, which require more intensive therapies. Hemoptysis and pneumothorax are complications commonly reported in patients with cystic fibrosis. Objectives: This document presents the CF Foundation's Pulmonary Therapies Committee recommendations for the treatment of hemoptysis and pneumothorax. Methods: The committee recognized that insufficient data exist to develop evidence-based recommendations and so used the Delphi technique to formalize an expert panel's consensus process and develop explicit care recommendations. Measurements and Main Results: The expert panel completed the survey twice, allowing refinement of recommendations. Numeric responses to the questions were summarized and applied to a priori definitions to determine levels of consensus. Recommendations were then developed to practical treatment questions based upon the median scores and the degree of consensus. Conclusions: These recommendations for the management of the patient with CF with hemoptysis and pneumothorax are designed for general use in most individuals but should be adapted to meet specific needs as determined by the individuals, their families, and their health care providers. It ishopedthat the guidelines providedin this manuscript will facilitate the appropriate application of these treatments to improve and extend the lives of all individuals with cystic fibrosis.

KW - Complications

KW - Cystic fibrosis

KW - Guidelines

KW - Hemoptysis

KW - Pneumothorax

UR - http://www.scopus.com/inward/record.url?scp=85047686252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047686252&partnerID=8YFLogxK

U2 - 10.1164/rccm.201002-0157OC

DO - 10.1164/rccm.201002-0157OC

M3 - Review article

C2 - 20675678

AN - SCOPUS:85047686252

VL - 182

SP - 298

EP - 306

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 3

ER -